Orexigen Therapeutics Inc. · San Diego, CA United States (NASDAQ: OREX)
| 12841 High Bluff Dr., Ste. 160 | Phone: 858-436-8600 |
| San Diego, CA | Fax: 858-436-8650 |
| 92130 | |
| United States | 
Map This Company |
Orexigen Therapeutics Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Orexigen Therapeutics thinks it has the skinny on how to stay trim. The company is developing drugs, under the names Contrave and Empatic (formerly Excalia), intended for use by obese people who are trying to get a grip on the urge to over-eat. The products are designed to control appetite from the central nervous system and contain some of the same chemicals used in drugs approved for the treatment of smoking, alcoholism, and opiate addiction. The development-stage company is conducting late-stage clinical trials on its top two drug candidates.
Orexigen Therapeutics Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: OREX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 34 |
Executives
27 executives listed for Orexigen Therapeutics Inc.'s San Diego, CA location.
| Chairman | Eckard Weber | |
|---|---|---|
| President, CEO, and Director | Michael Narachi | |
| CFO and Treasurer | Graham Cooper |